The 22nd Annual Norman P. Salzman Memorial Awards and Symposium in Basic and Clinical Virology Monday, November 9, 2020 Due to the COVID-19 pandemic, caused by SARS-CoV-2, this event is fully virtual for the first time in the symposium's history. Norman P. Salzman, Ph.D. Dr. Norman P. Salzman was a noted pioneer in the field of molecular virology and a founding editor of the Journal of Virology. In 1967 Dr. Salzman became Chief of the Laboratory of Biology of Viruses at the National Institute of Allergy and Infectious Diseases (NIAID) where he encouraged independence and excellence among his Fellows. Upon his retirement from NIH in 1986, Dr. Salzman moved to Georgetown University to head the Laboratory of Molecular Retrovirology, where he began his research on AIDS. This important work continued after he moved his laboratory in 1994 to the Frederick Cancer and Development Center (SAIC Program), where Dr. Salzman was appointed Director of an innovative mentoring program for post-doctoral fellows. Dr. Salzman was among the first to characterize viral mRNAs and to visualize replicating viral DNA. During his distinguished career at NIH, Dr. Salzman made many important and innovative contributions to our basic understanding of the replication of poliovirus, vaccinia virus, polyoma virus, SV40 virus and BK virus. Dr. Salzman’s studies on human immunodeficiency virus led to his discovery that ongoing evolution of viral quasi-species, despite combination antiretroviral therapy, characterized the relationship among viruses from different compartments and elucidated novel mechanisms of antiretroviral drug resistance. This work set the stage for todays’ work focusing on the role of viral reservoirs and challenges to HIV cure. Dr. Salzman’s memorable achievements in virology are paralleled by the recognition that his laboratory was a training ground for many young scientists, several of whom went on to become laboratory or section Chiefs at the NIH, and others to hold leadership positions in academia and industry all over the world. Six have been elected to the National Academy of Sciences and one received the Nobel Prize. - H. Clifford Lane, M.D., NIAID Norman P. Salzman Memorial Awards and Twenty-Second Annual Symposium in Basic and Clinical Virology 9:00 – 9:10 AM Welcome Nihal Altan-Bonnet, Ph.D., NHLBI, NIH 9:10 – 9:20 AM A Noble Salute Harvey J. Alter, M.D., MACP, Distinguished NIH Scientist Emeritus, 2020 Nobel Laureate in Physiology or Medicine 9:20 – 9:25 AM Foundation for the National Institutes of Health Maria C. Freire, Ph.D., President and Executive Director, FNIH 9:25 – 10:00 AM Keynote Presentation Perspectives for active and passive immunization after Covid-19 acceleration Rino Rappuoli, Ph.D., GlaxoSmithKline (GSK) 10:00 – 10:35 AM Coronaviruses: Old and New Susan R. Weiss, Ph.D., University of Pennsylvania 10:35 – 10:50 AM Tribute to Dr. Norman P. Salzman Marshall Bloom, M.D, Rocky Mountain Laboratories, NIAID, NIH 10:50 – 11:00 AM Presentation of the 2020 Norman P. Salzman Memorial Awards in Basic and Clinical Virology Lenore Salzman 11:00 – 11:25 AM Postdoctoral Fellow Award Lecture SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness Kizzmekia S. Corbett, Ph.D., NIAID, NIH 11:25 – 12:00 PM Human metapneumovirus: How it moves from cell to cell Rebecca Dutch, Ph.D., University of Kentucky 12:00 – 1:00 PM Lunch Break 1:00 – 1:35 PM Flavivirus Structure – Maybe a lot more complicated (interesting!) than we thought Richard Kuhn, Ph.D., Purdue University 1:35 – 2:00 PM Graduate Student Award Lecture Neutralization of Nipah virus via antibody-mediated targeting of the fusion glycoprotein Victoria A. Avanzato, NIAID, NIH 2:00 – 2:35 PM Lessons from novel viruses in infection and immunity David Wang, Ph.D., Washington University School of Medicine in St. Louis 2:35 – 3:10 PM Assessing the evolutionary potential of SARS-CoV-2 Jesse Bloom, Ph.D., Fred Hutchinson Cancer Research Center 3:10 – 3:15 PM Closing Remarks Paolo Lusso, M.D., Ph.D., NIAID, NIH The 2020 Norman P. Salzman Memorial Postdoctoral Fellow Award in Basic and Clinical Virology Kizzmekia S. Corbett, Ph.D. Viral Pathogenesis Laboratory Vaccine Research Center, NIAID, NIH Dr. Kizzmekia S. Corbett is a research fellow in the Viral Pathogenesis Laboratory at the National Institutes of Health, National Institute of Allergy and Infectious Diseases, Vaccine Research Center, where she works under the direction of the VRC’s Deputy Director, Dr. Barney S. Graham. She received a BS in Biological Sciences, with a secondary major in Sociology, in 2008 from the University of Maryland – Baltimore County, where she was a Meyerhoff Scholar and a NIH undergraduate scholar. She then obtained a PhD in Microbiology and Immunology from the University of North Carolina at Chapel Hill School of Medicine in 2014. A viral immunologist by training, her current work propels development of novel coronavirus vaccines and antibody therapies, including mRNA-1273, a leading candidate vaccine against the virus that causes COVID-19. In all, she has fifteen years of expertise studying dengue virus, respiratory syncytial virus, influenza virus, and coronaviruses. Along with her research activities, Dr. Corbett is an active member of the NIH Fellows Committee and avid advocator of STEM education and vaccine awareness in underserved communities. Combining her research goals with her knack for mentoring, Dr. Corbett aims to become an independent principal investigator. The 2020 Norman P. Salzman Memorial Mentor of Postdoctoral Fellow Award in Basic and Clinical Virology Barney S. Graham, M.D., Ph.D. Deputy Director, Vaccine Research Center, NIAID, NIH Chief, Viral Pathogenesis Laboratory Dr. Graham is Deputy Director and Chief of the Viral Pathogenesis Laboratory at the NIAID Vaccine Research Center. He has a BA from Rice University, an MD from the University of Kansas School of Medicine, and a PhD in Microbiology & Immunology from Vanderbilt University School of Medicine where he also completed Internal Medicine residency, chief residencies, and a fellowship in Infectious Diseases. His primary interests are vaccine development for viral diseases, viral pathogenesis, and mechanisms of immunity and pandemic preparedness. He currently directs basic laboratory research, contributes to the pipeline of new VRC vaccines, and provides oversight of candidate VRC vaccines and antibodies in advanced development including those for HIV, Ebola, and Chikungunya. His laboratory explores the structural basis for antibody-mediated viral neutralization, investigates basic mechanisms by which T cells affect viral clearance and immunopathology, and has developed novel vaccines for RSV, influenza, Zika, and coronaviruses including the first COVID-19 vaccine and monoclonal antibody products to enter clinical testing. The 2020 Norman P. Salzman Memorial Graduate Student Award in Basic and Clinical Virology Victoria A. Avanzato Virus Ecology Section, Laboratory of Virology, NIAID, NIH Vicky received her B.S. degrees in Immunology and Infectious Disease, and Toxicology, from The Pennsylvania State University, Schreyer Honors College, in 2015. She is currently pursuing her MD and PhD degrees through the NIH Oxford-Cambridge Scholars program and Emory University School of Medicine. Her dissertation research focuses on characterizing neutralizing epitopes on the Nipah virus surface glycoproteins using a combination of structural biology and animal models under the supervision of Vincent J. Munster (NIH) and Thomas A. Bowden (University of Oxford). She has also optimized serology assays to study the antibody response to SARS-CoV-2 infection and vaccination, and studied the long-term shedding of infectious SARS-CoV-2 from an immunocompromised patient. After the completion of her MD/PhD training, Vicky plans to become an infectious disease physician, while continuing to research antibody responses to emerging viral pathogens and global health. The 2020 Norman P. Salzman Memorial Mentors of Graduate Student Award in Basic and Clinical Virology Vincent Munster, Ph.D. Dr. Thomas Bowden Chief Virus Ecology Section, Rocky Mountain Division of Structural Biology, Wellcome Centre Laboratories, NIAID, NIH for Human Genetics, University of Oxford Dr. Vincent Munster is the chief of Dr. Thomas Bowden is an MRC the Virus Ecology Section at NIAIDs Senior Non-Clinical Research Rocky Mountain Laboratories. He Fellow in the Division of Structural received his Ph.D. in virology from Biology, Wellcome Centre for Erasmus University, Rotterdam, Human Genetics, University of the Netherlands, in 2006. During Oxford. Prior to becoming a his Ph.D. studies, Dr. Munster Principal Investigator, he studied studied the ecology, evolution, and emerging viruses at Scripps pathogenesis of avian influenza Research, the University of St viruses. He continued his training Andrews, and the University of at the Erasmus Medical Center Oxford as a Sir Henry Wellcome from 2006 to 2009, where he Post-doctoral Fellow. His worked within the Center for Research on Influenza Pathogenesis laboratory utilizes methods in structural biology to provide and Surveillance (CRIPS) focusing on pathogenicity and human-to- molecular-level insights into RNA virus glycoprotein architecture human transmission of influenza A viruses. Dr. Munster joined the and functionality. He has a particular interest in the host- NIAIDs Laboratory of Virology as a visiting fellow in 2009 to study interactions of emerging RNA viruses, such as Rift Valley fever virus, the ecology of emerging viruses such as Ebola virus. In 2013, Dr. Nipah virus, and hantaviruses, and applying structural information Munster established the Virus Ecology Unit as an independent to inform vaccine and antiviral development. tenure-track investigator. His lab is working to elucidate the ecology of emerging viruses and drivers of zoonotic and cross- species transmission. The lab uses a combined field and experimental research approach and conducts research at the state-of-the-art high- and maximum-containment facilities of the Rocky Mountain Laboratories, as well as at field study sites in Africa (the Republic of the Congo, Mali, Ghana, Liberia) and the Middle East (Jordan).